ASKA Pharmaceutical Holdings Co (TSE:4886) Cash And Cash Equivalents : 円17,454 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Cash And Cash Equivalents?

ASKA Pharmaceutical Holdings Co's quarterly cash and cash equivalents increased from Jun. 2023 (円15,183.00 Mil) to Sep. 2023 (円17,446.00 Mil) and increased from Sep. 2023 (円17,446.00 Mil) to Dec. 2023 (円17,454.00 Mil).

ASKA Pharmaceutical Holdings Co's annual cash and cash equivalents increased from Mar. 2022 (円12,103.00 Mil) to Mar. 2023 (円14,505.00 Mil) but then declined from Mar. 2023 (円14,505.00 Mil) to Mar. 2024 (円13,738.00 Mil).

ASKA Pharmaceutical Holdings Co Cash And Cash Equivalents Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Cash And Cash Equivalents Chart

ASKA Pharmaceutical Holdings Co Annual Data

Trend

Mar22

Mar23

Mar24

Cash And Cash Equivalents

12,103.00

14,505.00

13,738.00

ASKA Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial							14,505.00	15,183.00	17,446.00	17,454.00	13,738.00

ASKA Pharmaceutical Holdings Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

ASKA Pharmaceutical Holdings Co (TSE:4886) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

ASKA Pharmaceutical Holdings Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532

Website

https://www.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines